 |
인쇄하기
취소
|
Fluoroquinolone Factive acquires approval from US FDA
An antibiotic "Factive" developed by a local drug manufacturer has obtained an approval from the US FDA for the first time in Korea.
LG Life Sciences said recently that Factive (gemifloxacin) received an approvable letter from the FDA via its American strategic partner GeneSoft.
In the wake of the FDA approval, LG plans to launch its global marketing of Factiv with Genesoft and this antib...
LG Life Sciences said recently that Factive (gemifloxacin) received an approvable letter from the FDA via its American strategic partner GeneSoft.
In the wake of the FDA approval, LG plans to launch its global marketing of Factiv with Genesoft and this antib...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.